Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi jewish breast cancer families. Nat Med 2(11):1179–1183

Article  CAS  PubMed  Google Scholar 

Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi jews. N Engl J Med 336(20):1401–1408

Article  CAS  PubMed  Google Scholar 

Rubinstein WS (2004) Hereditary breast cancer in jews. Fam Cancer 3(3–4):249–257

Article  CAS  PubMed  Google Scholar 

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K et al (2015) Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing. J Natl Cancer Inst 107(1):380

Article  PubMed  Google Scholar 

Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S et al (2015) Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-jewish community: a randomized controlled trial. J Natl Cancer Inst 107(1):379

Article  PubMed  Google Scholar 

Grazi RV, Wolowelsky JB (2015) Cultural concerns when Counseling Orthodox jewish couples for genetic screening and PGD. J Genet Couns 24(6):878–881

Article  PubMed  Google Scholar 

Coleman-Brueckheimer K, Dein S (2011) Health care behaviours and beliefs in hasidic jewish populations: a systematic review of the literature. J Relig Health 50(2):422–436

Article  PubMed  Google Scholar 

Phillips KA, Warner E, Meschino WS, Hunter J, Abdolell M, Glendon G et al (2000) Perceptions of Ashkenazi jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2. Clin Genet 57(5):376–383

Article  CAS  PubMed  Google Scholar 

Reisel D, Burnell M, Side L, Loggenberg K, Gessler S, Desai R et al (2022) Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study. BJOG 129(6):959–968

Article  CAS  PubMed  Google Scholar 

Trivedi MS, Colbeth H, Yi H, Vanegas A, Starck R, Chung WK et al (2018) Understanding factors Associated with Uptake of BRCA1/2 genetic testing among Orthodox jewish women in the USA using a mixed-methods Approach. Public Health Genomics 21(5–6):186–196

Article  PubMed  Google Scholar 

Yi H, Trivedi MS, Crew KD, Schechter I, Appelbaum PS, Chung WK, Allegrante JP, Kukafka R (2024) Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community. Public Health Genomics. 2024 Feb 23. [Epub ahead of print]

Tang EY, Trivedi MS, Kukafka R, Chung WK, David R, Respler L et al Population-based study of attitudes toward BRCA genetic testing among Orthodox jewish women. The breast journal. 2016 Nov 30.

Kukafka R, Pan S, Silverman T, Zhang T, Chung WK, Terry MB et al (2022) Patient and clinician decision support to increase genetic counseling for Hereditary breast and ovarian Cancer syndrome in primary care: a Cluster Randomized Clinical Trial. JAMA Netw Open 5(7):e2222092

Article  PubMed  PubMed Central  Google Scholar 

Kukafka R, Fang J, Vanegas A, Silverman T, Crew KD (2018) Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting. BMC Med Inf Decis Mak 18(1):134

Article  Google Scholar 

Sarkar U, Schillinger D, Lopez A, Sudore R (2011) Validation of self-reported health literacy questions among diverse English and Spanish-speaking populations. J Gen Intern Med 26(3):265–271

Article  PubMed  Google Scholar 

Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM (2007 Sep-Oct) Measuring numeracy without a math test: development of the subjective numeracy scale. Med Decis Mak 27(5):672–680

Armstrong K, Micco E, Carney A, Stopfer J, Putt M (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293(14):1729–1736

Article  CAS  PubMed  Google Scholar 

Lerman C, Narod S, Schulman K, Hughes C, Gomez-Caminero A, Bonney G et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA: J Am Med Association 275(24):1885–1892

Article  CAS  Google Scholar 

O’Connor AM (1995 Jan-Mar) Validation of a decisional conflict scale. Med Decis Mak 15(1):25–30

Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ (2007) Validating the theoretical structure of the treatment self-regulation questionnaire (TSRQ) across three different health behaviors. Health Educ Res 22(5):691–702

Article  PubMed  Google Scholar 

O’Connor A (1995) User Manual: Decisional Self Efficacy Scale [updated in 2005]

Sussner KM, Edwards TA, Thompson HS, Jandorf L, Kwate NO, Forman A et al (2011) Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City. Public Health Genomics 14(6):356–370

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S et al (2019) Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi jewish population: a cohort study. BJOG 126(6):784–794

Article  CAS  PubMed  Google Scholar 

Lehmann LS, Weeks JC, Klar N, Garber JE (2002 Sep-Oct) A population-based study of Ashkenazi Jewish women’s attitudes toward genetic discrimination and BRCA1/2 testing. Genetics in medicine: official journal of the American College of Medical Genetics. 4(5):346–352

Dorff EN (1997) Jewish theological and Moral reflections on genetic screening: the case of BRCA1. Health Matrix. ;65